Kirsten Tolstrup | medicine | Best Researcher Award

Dr. Kirsten Tolstrup | Medicine | Best Researcher Award

Doctorate at UCSF School of Medicine, United States

👨‍🎓Professional Profile

👩‍⚕️ Summary

Dr. Kirsten Tolstrup is a distinguished cardiologist with extensive experience in cardiovascular disease, adult comprehensive echocardiography, and women’s heart health. With certifications in Internal Medicine, Cardiovascular Disease, and Echocardiography, she has held leadership roles at prominent institutions such as UCSF, Cedars-Sinai, and UNM. She is currently the Associate Chief of Cardiology at UCSF and serves as the Interim Medical Director of the HVC in the Division of Cardiology.

🎓 Education

Dr. Tolstrup completed her MD at the University of Copenhagen, Denmark, in 1993. She holds a BS from the University of Copenhagen, obtained in 1988. She pursued her Internal Medicine Residency at USC-LAC Medical Center in Los Angeles (1995-1998) and completed a Cardiovascular Medicine Fellowship at the UNM Health Sciences Center in Albuquerque (1998-2001).

💼 Professional Experience

Throughout her career, Dr. Tolstrup has held key roles, including Associate Chief of Cardiology at UCSF (2020-present), Medical Director of the Heart Station and Echo Laboratory at UNM (2012-2016), and Director of the Cardiac Non-invasive Stress Laboratory at Cedars-Sinai (2009-2012). She has also served as an Associate Clinical Professor at UCLA and Professor of Medicine at UCSF.

📚 Academic Citations

Dr. Tolstrup has made significant academic contributions, authoring chapters in notable medical texts such as Current Diagnosis and Treatment in Cardiology and The Ultimate Echo Guide. She has contributed to clinical guidelines on the use of echocardiography for cardiac embolism and heart disease in pregnancy.

🛠️ Technical Skills

She is highly skilled in adult comprehensive echocardiography and non-invasive cardiovascular imaging, with expertise in cardiac diagnostics and advanced echocardiographic techniques. Her technical proficiency also extends to cardiovascular risk assessment and imaging.

👩‍🏫 Teaching Experience

Dr. Tolstrup has shared her knowledge through teaching roles, including as a Teaching Associate at UCLA and Professor of Medicine at UCSF. She also served as an Instructor/Master at Dynamic Taekwondo Academy and remains actively involved in mentoring and instructing future cardiologists.

🔬 Research Interests

Her research interests focus on cardiovascular imaging, particularly in the areas of women’s heart health, aortic diseases, and heart failure. Dr. Tolstrup is dedicated to advancing the clinical applications of echocardiography and understanding cardiovascular risks across diverse populations.

📖Top Noted Publications

Very low prevalence and incidence of atrial fibrillation among Bolivian forager-farmers

Authors: Rowan, C.J., Eskander, M.A., Seabright, E., Kaplan, H.S., Gurven, M.D.
Journal: Annals of Global Health
Year: 2021

Update on Bicuspid Aortic Valve Syndrome: Patient Selection and Therapies in 2020

Authors: Anderson, D., Grober, A., Mahadevan, V., Tolstrup, K.
Journal: Current Treatment Options in Cardiovascular Medicine
Year: 2020

The clinical application of the ratio of transmitral early filling velocity to early diastolic strain rate: a systematic review and meta-analysis

Authors: Lassen, M.C.H., Olsen, F.J., Skaarup, K.G., Gislason, G., Biering-Sørensen, T.
Journal: Journal of Echocardiography
Year: 2020

 A Case-Based Discussion on the Management of Cryptogenic Stroke and Patent Foramen Ovale in the Patient With a Hypercoagulable Disorder

Authors: Gerstein, N.S., Clegg, S.D., Levin, D.B., Yoshida, Y., Homma, S.
Journal: Journal of Cardiothoracic and Vascular Anesthesia
Year: 2019

Ratio of transmitral early filling velocity to early diastolic strain rate predicts long-term risk of cardiovascular morbidity and mortality in the general population

Authors: Lassen, M.C.Hø., Biering-Sørensen, S.R., Olsen, F.J., Jensen, J.S., Biering-Sørensen, T.
Journal: European Heart Journal
Year: 2019

Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism

Authors: Saric, M., Armour, A.C., Arnaout, M.S., Michelena, H.I., Tolstrup, K.
Journal: Journal of the American Society of Echocardiography
Year: 2016

Laurence Vaughan | Medical Diagnostics | Best Researcher Award

Dr. Laurence Vaughan | Medical Diagnostics | Best Researcher Award

Dr. Laurence Vaughan at Becton Dickinson and Company, United States

👨‍🎓 Professional Profile

🎓 Early Academic Pursuits

Dr. Laurence Vaughan began his academic journey at the University of Dublin, Trinity College, where he earned a BA (Honors) in Natural Sciences (Genetics) in 1986, followed by a Ph.D. in Molecular Microbiology in 1991. His doctoral research focused on the aroA gene of Aeromonas salmonicida, contributing to foundational knowledge in microbiology and vaccine development.

🏢 Professional Endeavors

Dr. Vaughan’s career spans over three decades in the biotechnology and molecular diagnostics sectors. Currently, he serves as the Director of Scientific Affairs at Becton Dickinson and Company, focusing on integrated diagnostic solutions for women’s health, particularly cervical cancer screening. His past roles include R&D leadership at QIAGEN and Corning Incorporated, where he made significant advancements in molecular assay development and product support.

🌟 Contributions and Research Focus

Dr. Vaughan has led teams in developing groundbreaking products such as the BD Onclarity cervical cancer screening test, which received CE Mark approval in 2014 and US-PMA approval in 2018. He has authored content for international conferences and peer-reviewed publications, emphasizing his commitment to advancing scientific knowledge and product innovation in the diagnostics field.

🌍 Impact and Influence

His work has not only shaped diagnostic guidelines but has also influenced industry standards, as seen with the American Society for Colposcopy and Cervical Pathology (ASCCP) management guidelines launched in 2020. Dr. Vaughan’s expertise is recognized internationally, making him a sought-after speaker at various conferences.

📚 Academic Cites

Dr. Vaughan has made notable contributions to the field of vaccinology, evidenced by multiple patents and publications. His editorial experience as the Editor-in-Chief of “Diseases of Aquatic Organisms” from 1995 to 1999 further underscores his leadership in academic discourse.

🔧 Technical Skills

Dr. Vaughan possesses extensive technical skills in molecular biology, microbiology, and genetics. His proficiency in managing clinical trials, particularly in the R&D lead for Onclarity HPV clinical trials, highlights his ability to oversee complex scientific projects.

👩‍🏫 Teaching Experience

Throughout his career, Dr. Vaughan has demonstrated a passion for education and mentorship. He has developed and delivered training for global customers and internal teams, showcasing his strong communication and interpersonal skills.

🏅 Legacy and Future Contributions

Dr. Vaughan’s legacy includes a robust portfolio of innovations and leadership in the biotech field. His achievements, such as the Becton Dickinson Wesley J. Howe Award for Technological Innovation in 2013, reflect his dedication to advancing science and technology. Looking ahead, he aims to continue contributing to the development of effective diagnostic solutions and vaccines, focusing on emerging health challenges.

 

📖 Top Noted Publications

Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening

Authors: Vaughan, L., Gary, D., Shah, M., Galbraith, L., Parvu, V.
Journal: Gynecologic Oncology Reports
Year: 2024

Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial

Authors: Stoler, M.H., Parvu, V., Yanson, K., Andrews, J., Vaughan, L.
Journal: Gynecologic Oncology
Year: 2023

Validation of a New High-Throughput BD COR System Using the BD CTGCTV2 Assay

Authors: Taylor, S., Rucki, A., Lockamy, E., Vaughan, L., Greene, W.
Journal: Journal of Molecular Diagnostics
Year: 2022

Evaluation of the Onclarity HPV assay on the high-throughput COR system

Authors: Taylor, S.N., Eckert, K., Rucki, A.A., Vaughan, L.M., Greene, W.H.
Journal: Expert Review of Molecular Diagnostics
Year: 2021

Cotesting in cervical cancer screening

Authors: Malinowski, D.P., Broache, M., Vaughan, L., Andrews, J., Gary, D.
Journal: American Journal of Clinical Pathology
Year: 2021

Analytical and clinical sample performance characteristics of the onclarity assay for the detection of human papillomavirus

Authors: Young, S., Vaughan, L., Yanson, K., Cooper, C.K., van der Pol, B.
Journal: Journal of Clinical Microbiology
Year: 2021